NCAM1 and glioma: In addition, TIM-3+ NK cells secreted less IFNγ compared to TIM-3- NK cells and glioma patients with higher percentage of TIM-3 positivity on their surface, and peripheral CD3- CD56+ NK cells also had higher levels of proliferative tumor cells as measured by Ki-67 expression levels.